ID   S22A4_HUMAN             Reviewed;         551 AA.
AC   Q9H015; O14546;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 3.
DT   10-MAY-2017, entry version 143.
DE   RecName: Full=Solute carrier family 22 member 4;
DE   AltName: Full=Ergothioneine transporter;
DE            Short=ET transporter;
DE   AltName: Full=Organic cation/carnitine transporter 1;
GN   Name=SLC22A4; Synonyms=ETT, OCTN1, UT2H;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND VARIANTS THR-306 AND PHE-503.
RC   TISSUE=Fetal liver;
RX   PubMed=9426230; DOI=10.1016/S0014-5793(97)01441-5;
RA   Tamai I., Yabuuchi H., Nezu J., Sai Y., Oku A., Shimane M., Tsuji A.;
RT   "Cloning and characterization of a novel human pH-dependent organic
RT   cation transporter, OCTN1.";
RL   FEBS Lett. 419:107-111(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=15795384; DOI=10.1073/pnas.0408624102;
RA   Gruendemann D., Harlfinger S., Golz S., Geerts A., Lazar A.,
RA   Berkels R., Jung N., Rubbert A., Schoemig E.;
RT   "Discovery of the ergothioneine transporter.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:5256-5261(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=10215651;
RA   Yabuuchi H., Tamai I., Nezu J., Sakamoto K., Oku A., Shimane M.,
RA   Sai Y., Tsuji A.;
RT   "Novel membrane transporter OCTN1 mediates multispecific,
RT   bidirectional, and pH-dependent transport of organic cations.";
RL   J. Pharmacol. Exp. Ther. 289:768-773(1999).
RN   [6]
RP   INDUCTION, TISSUE SPECIFICITY, AND INVOLVEMENT IN RA.
RX   PubMed=14608356; DOI=10.1038/ng1267;
RA   Tokuhiro S., Yamada R., Chang X., Suzuki A., Kochi Y., Sawada T.,
RA   Suzuki M., Nagasaki M., Ohtsuki M., Ono M., Furukawa H., Nagashima M.,
RA   Yoshino S., Mabuchi A., Sekine A., Saito S., Takahashi A., Tsunoda T.,
RA   Nakamura Y., Yamamoto K.;
RT   "An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an
RT   organic cation transporter, is associated with rheumatoid arthritis.";
RL   Nat. Genet. 35:341-348(2003).
RN   [7]
RP   VARIANTS THR-306 AND GLU-462.
RX   PubMed=12436193; DOI=10.1007/s100380200088;
RA   Saito S., Iida A., Sekine A., Ogawa C., Kawauchi S., Higuchi S.,
RA   Nakamura Y.;
RT   "Catalog of 238 variations among six human genes encoding solute
RT   carriers (hSLCs) in the Japanese population.";
RL   J. Hum. Genet. 47:576-584(2002).
RN   [8]
RP   CHARACTERIZATION OF VARIANT GLU-462, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=15459889; DOI=10.1002/jps.20190;
RA   Kawasaki Y., Kato Y., Sai Y., Tsuji A.;
RT   "Functional characterization of human organic cation transporter OCTN1
RT   single nucleotide polymorphisms in the Japanese population.";
RL   J. Pharm. Sci. 93:2920-2926(2004).
RN   [9]
RP   VARIANT PHE-503, AND TISSUE SPECIFICITY.
RX   PubMed=15107849; DOI=10.1038/ng1339;
RA   Peltekova V.D., Wintle R.F., Rubin L.A., Amos C.I., Huang Q., Gu X.,
RA   Newman B., Van Oene M., Cescon D., Greenberg G., Griffiths A.M.,
RA   St George-Hyslop P.H., Siminovitch K.A.;
RT   "Functional variants of OCTN cation transporter genes are associated
RT   with Crohn disease.";
RL   Nat. Genet. 36:471-475(2004).
CC   -!- FUNCTION: Sodium-ion dependent, low affinity carnitine
CC       transporter. Probably transports one sodium ion with one molecule
CC       of carnitine. Also transports organic cations such as
CC       tetraethylammonium (TEA) without the involvement of sodium.
CC       Relative uptake activity ratio of carnitine to TEA is 1.78. A key
CC       substrate of this transporter seems to be ergothioneine (ET).
CC       {ECO:0000269|PubMed:10215651, ECO:0000269|PubMed:15795384}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.470 mM for TEA (at 37 degrees Celsius and pH 7.4)
CC         {ECO:0000269|PubMed:15459889, ECO:0000269|PubMed:9426230};
CC         Vmax=0.974 nmol/min/mg enzyme toward TEA (at 37 degrees Celsius
CC         and pH 7.4) {ECO:0000269|PubMed:15459889,
CC         ECO:0000269|PubMed:9426230};
CC       pH dependence:
CC         More active at neutral and alkaline pHs than at acidic pHs.
CC         {ECO:0000269|PubMed:15459889, ECO:0000269|PubMed:9426230};
CC   -!- SUBUNIT: Interacts with PDZK1. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in whole
CC       blood, bone marrow, trachea and fetal liver. Weakly expressed in
CC       kidney, skeletal muscle, prostate, lung, pancreas, placenta,
CC       heart, uterus, spleen and spinal cord. Highly expressed in
CC       intestinal cell types affected by Crohn disease, including
CC       epithelial cells. Expressed in CD68 macrophage and CD43 T-cells
CC       but not in CD20 B-cells. Predominantly expressed in CD14 cells in
CC       peripheral blood mononuclear cells. {ECO:0000269|PubMed:14608356,
CC       ECO:0000269|PubMed:15107849, ECO:0000269|PubMed:9426230}.
CC   -!- INDUCTION: Overexpressed upon TNF treatment.
CC       {ECO:0000269|PubMed:14608356}.
CC   -!- DISEASE: Rheumatoid arthritis (RA) [MIM:180300]: An inflammatory
CC       disease with autoimmune features and a complex genetic component.
CC       It primarily affects the joints and is characterized by
CC       inflammatory changes in the synovial membranes and articular
CC       structures, widespread fibrinoid degeneration of the collagen
CC       fibers in mesenchymal tissues, and by atrophy and rarefaction of
CC       bony structures. {ECO:0000269|PubMed:14608356}. Note=Disease
CC       susceptibility is associated with variations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the major facilitator (TC 2.A.1)
CC       superfamily. Organic cation transporter (TC 2.A.1.19) family.
CC       {ECO:0000305}.
CC   -!- CAUTION: PubMed:9426230 reported that this protein does not
CC       transport carnitine, however, experiments were done with the Phe-
CC       503 variant, which affects the ability to transport carnitine.
CC       PubMed:15459889 showed that, although weakly, it can also
CC       transport carnitine at some level. Its function in carnitine
CC       transport is therefore unclear. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB007448; BAA23356.1; -; mRNA.
DR   EMBL; Y09881; CAA71007.1; -; mRNA.
DR   EMBL; AC008599; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC034220; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC028313; AAH28313.1; -; mRNA.
DR   CCDS; CCDS4153.1; -.
DR   RefSeq; NP_003050.2; NM_003059.2.
DR   UniGene; Hs.310591; -.
DR   ProteinModelPortal; Q9H015; -.
DR   BioGrid; 112470; 1.
DR   STRING; 9606.ENSP00000200652; -.
DR   ChEMBL; CHEMBL2073668; -.
DR   DrugBank; DB00594; Amiloride.
DR   DrugBank; DB00345; Aminohippuric acid.
DR   DrugBank; DB01053; Benzylpenicillin.
DR   DrugBank; DB00122; Choline.
DR   DrugBank; DB00501; Cimetidine.
DR   DrugBank; DB00575; Clonidine.
DR   DrugBank; DB01151; Desipramine.
DR   DrugBank; DB00536; Guanidine.
DR   DrugBank; DB00458; Imipramine.
DR   DrugBank; DB00332; Ipratropium bromide.
DR   DrugBank; DB00125; L-Arginine.
DR   DrugBank; DB00583; L-Carnitine.
DR   DrugBank; DB00123; L-Lysine.
DR   DrugBank; DB01137; Levofloxacin.
DR   DrugBank; DB06691; Mepyramine.
DR   DrugBank; DB00184; Nicotine.
DR   DrugBank; DB01165; Ofloxacin.
DR   DrugBank; DB01035; Procainamide.
DR   DrugBank; DB01917; Putrescine.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB00468; Quinine.
DR   DrugBank; DB03566; Spermidine.
DR   DrugBank; DB00127; Spermine.
DR   DrugBank; DB00624; Testosterone.
DR   DrugBank; DB08837; Tetraethylammonium.
DR   DrugBank; DB01409; Tiotropium.
DR   DrugBank; DB00661; Verapamil.
DR   TCDB; 2.A.1.19.2; the major facilitator superfamily (mfs).
DR   iPTMnet; Q9H015; -.
DR   PhosphoSitePlus; Q9H015; -.
DR   BioMuta; SLC22A4; -.
DR   DMDM; 146345508; -.
DR   PaxDb; Q9H015; -.
DR   PeptideAtlas; Q9H015; -.
DR   PRIDE; Q9H015; -.
DR   DNASU; 6583; -.
DR   Ensembl; ENST00000200652; ENSP00000200652; ENSG00000197208.
DR   GeneID; 6583; -.
DR   KEGG; hsa:6583; -.
DR   UCSC; uc003kwq.4; human.
DR   CTD; 6583; -.
DR   DisGeNET; 6583; -.
DR   GeneCards; SLC22A4; -.
DR   H-InvDB; HIX0024844; -.
DR   HGNC; HGNC:10968; SLC22A4.
DR   HPA; CAB015468; -.
DR   HPA; HPA036973; -.
DR   MalaCards; SLC22A4; -.
DR   MIM; 180300; phenotype.
DR   MIM; 604190; gene.
DR   neXtProt; NX_Q9H015; -.
DR   OpenTargets; ENSG00000197208; -.
DR   PharmGKB; PA332; -.
DR   eggNOG; ENOG410IRIE; Eukaryota.
DR   eggNOG; ENOG410XSRI; LUCA.
DR   GeneTree; ENSGT00760000118852; -.
DR   HOGENOM; HOG000234570; -.
DR   HOVERGEN; HBG061545; -.
DR   InParanoid; Q9H015; -.
DR   KO; K08202; -.
DR   OMA; IAIMTIM; -.
DR   OrthoDB; EOG091G05AC; -.
DR   PhylomeDB; Q9H015; -.
DR   TreeFam; TF315847; -.
DR   Reactome; R-HSA-549127; Organic cation transport.
DR   GeneWiki; SLC22A4; -.
DR   GenomeRNAi; 6583; -.
DR   PRO; PR:Q9H015; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000197208; -.
DR   CleanEx; HS_SLC22A4; -.
DR   Genevisible; Q9H015; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0015226; F:carnitine transmembrane transporter activity; IDA:MGI.
DR   GO; GO:0015491; F:cation:cation antiporter activity; IDA:BHF-UCL.
DR   GO; GO:0000166; F:nucleotide binding; TAS:ProtInc.
DR   GO; GO:0008514; F:organic anion transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:BHF-UCL.
DR   GO; GO:0015651; F:quaternary ammonium group transmembrane transporter activity; IDA:BHF-UCL.
DR   GO; GO:0008513; F:secondary active organic cation transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015293; F:symporter activity; IEA:UniProtKB-KW.
DR   GO; GO:0007589; P:body fluid secretion; TAS:ProtInc.
DR   GO; GO:0009437; P:carnitine metabolic process; IBA:GO_Central.
DR   GO; GO:0015879; P:carnitine transport; IDA:MGI.
DR   GO; GO:0015695; P:organic cation transport; TAS:ProtInc.
DR   GO; GO:0015697; P:quaternary ammonium group transport; IDA:BHF-UCL.
DR   GO; GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW.
DR   GO; GO:0006641; P:triglyceride metabolic process; IEA:Ensembl.
DR   CDD; cd06174; MFS; 1.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR005828; MFS_sugar_transport-like.
DR   InterPro; IPR004749; Orgcat_transp/SVOP.
DR   InterPro; IPR005829; Sugar_transporter_CS.
DR   Pfam; PF00083; Sugar_tr; 1.
DR   SUPFAM; SSF103473; SSF103473; 1.
DR   TIGRFAMs; TIGR00898; 2A0119; 1.
DR   PROSITE; PS50850; MFS; 1.
DR   PROSITE; PS00216; SUGAR_TRANSPORT_1; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Disease mutation; Glycoprotein;
KW   Ion transport; Membrane; Nucleotide-binding; Polymorphism;
KW   Reference proteome; Sodium; Sodium transport; Symport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    551       Solute carrier family 22 member 4.
FT                                /FTId=PRO_0000220497.
FT   TOPO_DOM      1     20       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     21     41       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     42    141       Extracellular. {ECO:0000255}.
FT   TRANSMEM    142    162       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    163    171       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    172    192       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    193    197       Extracellular. {ECO:0000255}.
FT   TRANSMEM    198    218       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    219    232       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    233    253       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    254    257       Extracellular. {ECO:0000255}.
FT   TRANSMEM    258    278       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    279    337       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    338    358       Helical; Name=7. {ECO:0000255}.
FT   TOPO_DOM    359    371       Extracellular. {ECO:0000255}.
FT   TRANSMEM    372    392       Helical; Name=8. {ECO:0000255}.
FT   TOPO_DOM    393    399       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    400    420       Helical; Name=9. {ECO:0000255}.
FT   TOPO_DOM    421    426       Extracellular. {ECO:0000255}.
FT   TRANSMEM    427    447       Helical; Name=10. {ECO:0000255}.
FT   TOPO_DOM    448    460       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    461    481       Helical; Name=11. {ECO:0000255}.
FT   TOPO_DOM    482    486       Extracellular. {ECO:0000255}.
FT   TRANSMEM    487    507       Helical; Name=12. {ECO:0000255}.
FT   TOPO_DOM    508    551       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     218    225       ATP. {ECO:0000255}.
FT   CARBOHYD     57     57       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     64     64       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     91     91       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     306    306       I -> T (in dbSNP:rs272893).
FT                                {ECO:0000269|PubMed:12436193,
FT                                ECO:0000269|PubMed:9426230}.
FT                                /FTId=VAR_019528.
FT   VARIANT     462    462       G -> E (abrogates TEA transport activity;
FT                                dbSNP:rs4646201).
FT                                {ECO:0000269|PubMed:12436193,
FT                                ECO:0000269|PubMed:15459889}.
FT                                /FTId=VAR_019529.
FT   VARIANT     503    503       L -> F (reduces the ability to transport
FT                                carnitine; dbSNP:rs1050152).
FT                                {ECO:0000269|PubMed:15107849,
FT                                ECO:0000269|PubMed:9426230}.
FT                                /FTId=VAR_019530.
SQ   SEQUENCE   551 AA;  62155 MW;  C827A99AA78C9443 CRC64;
     MRDYDEVIAF LGEWGPFQRL IFFLLSASII PNGFNGMSVV FLAGTPEHRC RVPDAANLSS
     AWRNNSVPLR LRDGREVPHS CSRYRLATIA NFSALGLEPG RDVDLGQLEQ ESCLDGWEFS
     QDVYLSTVVT EWNLVCEDNW KVPLTTSLFF VGVLLGSFVS GQLSDRFGRK NVLFATMAVQ
     TGFSFLQIFS ISWEMFTVLF VIVGMGQISN YVVAFILGTE ILGKSVRIIF STLGVCTFFA
     VGYMLLPLFA YFIRDWRMLL LALTVPGVLC VPLWWFIPES PRWLISQRRF REAEDIIQKA
     AKMNNIAVPA VIFDSVEELN PLKQQKAFIL DLFRTRNIAI MTIMSLLLWM LTSVGYFALS
     LDAPNLHGDA YLNCFLSALI EIPAYITAWL LLRTLPRRYI IAAVLFWGGG VLLFIQLVPV
     DYYFLSIGLV MLGKFGITSA FSMLYVFTAE LYPTLVRNMA VGVTSTASRV GSIIAPYFVY
     LGAYNRMLPY IVMGSLTVLI GILTLFFPES LGMTLPETLE QMQKVKWFRS GKKTRDSMET
     EENPKVLITA F
//
